Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+macrophage infiltration in mice
Author:
Affiliation:
1. Department of Medicine III; University Hospital Aachen; Aachen Germany
2. Institute of Pathology; University Hospital Aachen; Aachen Germany
3. Institute of Pathology; University Bonn; Bonn Germany
4. NOXXON Pharma AG; Berlin Germany
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26783/fullpdf
Reference33 articles.
1. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis;P;Proc Natl Acad Sci U S A,2012
2. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet,2013
3. Monocytes and macrophages as cellular targets in liver fibrosis;Heymann;Inflamm Allergy Drug Targets,2009
4. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis;Karlmark;Hepatology,2009
5. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis;Zimmermann;PLoS One,2010
Cited by 213 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis;Advanced Science;2024-08-29
2. Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy;Reviews in Medical Virology;2024-08-27
3. A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice;Molecular Metabolism;2024-06
4. Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics;Cell Death Discovery;2024-05-13
5. Current status and future perspectives of FGF21 analogues in clinical trials;Trends in Endocrinology & Metabolism;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3